You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell vaccine

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Influenza, Human Trial in Birmingham (Treatment Group Live Attenuated Flu Vaccine (LAIV))

Completed
  • Influenza, Human
  • Treatment Group Live Attenuated Flu Vaccine (LAIV)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 16, 2022

Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell

Recruiting
  • Hematologic Diseases
  • COVID-19 vaccine(donor)
  • COVID-19 vaccine(patient)
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Nov 8, 2022

Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,

Recruiting
  • Hand, Foot and Mouth Disease
  • Herpangina
  • low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
  • +3 more
  • Chuxiong, Yunnan, China
    Dayao County Center for Disease Control and Prevention
Sep 25, 2023

IsThird Dose of MMRV Vaccine Beneficial for Adult Population in

Not yet recruiting
  • Vaccination Failure
  • Vaccine Response Impaired
  • Serology for antibody levels - Baseline
  • +3 more
  • (no location specified)
Jun 26, 2023

NSCLC Trial in Baltimore (Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0.3mg each; 1.8mg total peptides)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0.3mg each; 1.8mg total peptides
  • Baltimore, Maryland
    Johns Hopkins University
Jun 16, 2022

Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell

Not yet recruiting
  • Cytomegaloviral Infection
  • Hematopoietic and Lymphoid System Neoplasm
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 16, 2022

COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy

Unknown status
  • Allogenic Hematopoietic Cell Transplant
  • +2 more
    • Tel-Aviv, Israel
      Tel-Aviv Sourasky Medical Center
    Jan 27, 2021

    B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • (no location specified)
    Oct 10, 2023

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Influenza Vaccine in Lung Transplant Patients - T Cells

    Completed
    • Influenza
    • Influenza vaccine
    • Madison, Wisconsin
      University of Wisconsin
    Oct 20, 2020

    Peripheral T Cell Lymphoma Trial in China (CAR-T Therapy)

    Not yet recruiting
    • Peripheral T Cell Lymphoma
    • CAR-T Therapy
    • Hefei, Anhui, China
    • +7 more
    Jul 31, 2023

    B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • CD19/CD22-bispecific CAR-T cells
    • Beijing, Beijing, China
      Liang Wang
    Oct 7, 2023

    Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy Trial in Durham (SCD-specific COVID-19 vaccination information (SCVI)

    Not yet recruiting
    • Sickle Cell Disease
    • +2 more
    • SCD-specific COVID-19 vaccination information (SCVI) video
    • Durham, North Carolina
      Duke Adult Sickle Cell Program
    Aug 17, 2023

    NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)

    Not yet recruiting
    • NSCLC Stage IV
    • ALK Fusion Protein Expression
    • Peptide vaccine
    • (no location specified)
    Jul 21, 2023

    Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Cutaneous T-cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 8, 2023

    Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer, Cervical Cancer Trial in France (biological, procedure, other,

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • +2 more
    • Blood sample collection
    • +4 more
    • Besançon, France
    • +4 more
    Nov 17, 2022

    T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

    Not yet recruiting
    • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • CD7-CART01
    • (no location specified)
    Sep 26, 2023

    ASCT Versus Chemotherapy as First-Line Consolidation Therapy

    Completed
    • T-cell Lymphoma Adults
    • consolidation with ASCT
    • (no location specified)
    Nov 25, 2023

    Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma, Refractory T-Cell Lymphoma Trial in Xiamen (Chidamide combined

    Recruiting
    • Peripheral T Cell Lymphoma
    • +2 more
    • Chidamide combined with Duvillisib
    • Xiamen, Fujian, China
      The First Affiliated Hosptial of Xiamen University
    Nov 28, 2023

    COVID-19 Trial (Recombinant variant COVID-19 vaccine (Sf9 cell), Recombinant COVID-19 vaccine (CHO cell), Recombinant COVID-19

    Not yet recruiting
    • COVID-19
    • Recombinant variant COVID-19 vaccine (Sf9 cell)
    • +2 more
    • (no location specified)
    Mar 10, 2023

    Melanoma Trial in Philadelphia (Mature dendritic cell (DC) vaccine, Cyclophosphamide 300mg/m^2, Pembrolizumab)

    Active, not recruiting
    • Melanoma
    • Mature dendritic cell (DC) vaccine
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Feb 2, 2023

    CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

    Not yet recruiting
    • Lymphoma
    • Chimeric Antigen Receptor
    • (no location specified)
    Oct 24, 2023

    T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)

    Recruiting
    • T-Cell Acute Lymphocytic Leukemia
    • CD7 CAR-T
    • Langfang, Hebei, China
      Hebei Yanda Hospital
    Jun 26, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022